Literature DB >> 15550943

Epidemiological interpretation of antibiotic resistance studies - what are we missing?

Mitchell J Schwaber1, Tali De-Medina, Yehuda Carmeli.   

Abstract

Antimicrobial resistance is an emerging public-health threat. Studies of the relationship between antibiotic use and resistance, as well as surveillance programmes, examine changes in the proportion of isolates that are resistant. Although proportions are helpful to the clinician prescribing empirical therapy, proportion-based analyses can be misleading to the public-health professional as they can yield biased estimates. Proportions do not adequately reflect the burden of resistance, a measure often of interest in public health. A more appropriate measure of this burden is the rate of isolation of resistant organisms, that is, the absolute number of resistant isolates in a population over time.

Mesh:

Substances:

Year:  2004        PMID: 15550943     DOI: 10.1038/nrmicro1047

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  21 in total

Review 1.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Authors:  Elizabeth Mostofsky; Marc Lipsitch; Gili Regev-Yochay
Journal:  J Antimicrob Chemother       Date:  2011-07-07       Impact factor: 5.790

Review 3.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

4.  Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.

Authors:  Minn M Soe; Jonathan R Edwards; Dawn M Sievert; Philip M Ricks; Shelley S Magill; Scott K Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

5.  Antimicrobial Resistance Following Azithromycin Mass Drug Administration: Potential Surveillance Strategies to Assess Public Health Impact.

Authors:  Ines Mack; Mike Sharland; James A Berkley; Nigel Klein; Surbhi Malhotra-Kumar; Julia Bielicki
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

6.  A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial.

Authors:  Lona Mody; Sarah L Krein; Sanjay Saint; Lillian C Min; Ana Montoya; Bonnie Lansing; Sara E McNamara; Kathleen Symons; Jay Fisch; Evonne Koo; Ruth Anne Rye; Andrzej Galecki; Mohammed U Kabeto; James T Fitzgerald; Russell N Olmsted; Carol A Kauffman; Suzanne F Bradley
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

7.  Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004.

Authors:  E Meyer; F Schwab; P Gastmeier; H Rueden; F D Daschner
Journal:  Infection       Date:  2006-12       Impact factor: 3.553

8.  Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Amy L Pakyz; Michael Oinonen; Ronald E Polk
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

9.  Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.

Authors:  Elisabeth Meyer; Matthias Lapatschek; Andreas Bechtold; Gerhard Schwarzkopf; Petra Gastmeier; Frank Schwab
Journal:  Intensive Care Med       Date:  2008-11-26       Impact factor: 17.440

10.  Semi-Automated Visualization and ANalysis of Trends: A "SAVANT" for Facilitating Antimicrobial Stewardship Using Antistaphylococcal Resistance and Consumption as a Prototype.

Authors:  Robert J Clifford; Uzo Chukwuma; Michael E Sparks; Douglas Richesson; Charlotte V Neumann; Paige E Waterman; Jacob Moran-Gilad; Michael D Julius; Mary K Hinkle; Emil P Lesho
Journal:  Open Forum Infect Dis       Date:  2018-03-23       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.